Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Means and standard deviations of the D95%, DSC, and Warpmean distributions of the PTV depending on the tumour location in the lung lobe. Meaningful differences were assessed by the P-value

From: Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy

Lung Lobe

N

D95%±SD [cGy]

DSC ± SD

Warpmean±SD[mm]

LUL

84

5920.0 ± 147.6

0.97 ± 0.04

1.57 ± 0.83

LLL

60

5775.1 ± 439.4

0.96 ± 0.06

1.92 ± 1.22

RUL

64

5889.5 ± 120.9

0.97 ± 0.04

1.51 ± 0.68

RML

16

5806.5 ± 189.7

0.98 ± 0.04

2.47 ± 1.07

RLL

64

5800.5 ± 349.8

0.96 ± 0.08

2.20 ± 1.39

Total

288

5850.2 ± 285.5

0.97 ± 0.06

1.82 ± 1.09

P-Value

 

0.012

0.189

0

  1. LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us